(16 May 2020) Hydroxychloroquine- no evidence for negative conversion of SARS-CoV-2
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial https://www.bmj.com/content/369/bmj.m1849 This study (conducted during the outbreak of covid-19 in China -ChiCTR2000029868) is the first randomised controlled trial evaluating administration of hydroxychloroquine in patients… Continue reading "(16 May 2020) Hydroxychloroquine- no evidence for negative conversion of SARS-CoV-2"